Literature DB >> 3016293

DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation.

E A Petrovskis, J G Timmins, M A Armentrout, C C Marchioli, R J Yancey, L E Post.   

Abstract

The DNA sequence was determined for a region of the pseudorabies virus (PRV) genome to which a mutation defining resistance to a monoclonal antibody has been mapped (M. W. Wathen and L. M. K. Wathen, J. Virol., 51:57-62, 1984). This sequence was found to contain an open reading frame that did not include an amino acid sequence directing N-linked glycosylation. This open reading frame was expressed in uninfected Chinese hamster ovary cells to produce the PRV glycoprotein gp50. When PRV-infected Vero cells were incubated in the presence of tunicamycin, the gp50 that was produced had an identical molecular weight to that produced in the absence of drug. When infected cells were incubated in the presence of monensin, the molecular weight of gp50 was reduced from 60,000 to 45,000, but was not sensitive to endo-beta-N-acetylglucosaminidase H. These observations led to the conclusion that gp50 does not contain N-linked carbohydrate, as predicted from the DNA sequence. A region of the amino acid sequence and the positions of the cysteine residues of PRV gp50 are homologous to glycoprotein D of herpes simplex virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016293      PMCID: PMC253069     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants.

Authors:  L S Morse; L Pereira; B Roizman; P A Schaffer
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

4.  Promoter-regulatory region of the major immediate early gene of human cytomegalovirus.

Authors:  D R Thomsen; R M Stenberg; W F Goins; M F Stinski
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1.

Authors:  A G Noble; G T Lee; R Sprague; M L Parish; P G Spear
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Synthesis of proteins in cells infected with herpesvirus. V. Viral glycoproteins.

Authors:  T Ben-Porat; A S Kaplan
Journal:  Virology       Date:  1970-06       Impact factor: 3.616

8.  Initial glycosylation of proteins with acetylgalactosaminylserine linkages.

Authors:  G J Strous
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor.

Authors:  R D Cummings; S Kornfeld; W J Schneider; K K Hobgood; H Tolleshaug; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

10.  Glycoprotein C of herpes simplex virus type 1: characterization of O-linked oligosaccharides.

Authors:  S Olofsson; I Sjöblom; M Lundström; S Jeansson; E Lycke
Journal:  J Gen Virol       Date:  1983-12       Impact factor: 3.891

View more
  54 in total

1.  Characterization of field isolates of suid herpesvirus 1 (Aujeszky's disease virus) as derivatives of attenuated vaccine strains.

Authors:  L S Christensen; I Medveczky; B S Strandbygaard; Z Pejsak
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus.

Authors:  M Eloit; P Vannier; E Hutet; A Fournier
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission.

Authors:  L Zsak; F Zuckermann; N Sugg; T Ben-Porat
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells.

Authors:  C C Marchioli; R J Yancey; E A Petrovskis; J G Timmins; L E Post
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Production of a baculovirus-derived gp50 protein and utilization in a competitive enzyme-linked immunosorbent assay for the serodiagnosis of pseudorabies virus.

Authors:  I Prud'homme; E M Zhou; M Traykova; H Trotter; M Chan; A Afshar; M J Harding
Journal:  Can J Vet Res       Date:  1997-10       Impact factor: 1.310

6.  Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.

Authors:  D L Sodora; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene.

Authors:  M S Parcells; A S Anderson; R W Morgan
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

8.  Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL.

Authors:  B G Klupp; J Baumeister; A Karger; N Visser; T C Mettenleiter
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Correlation between precolonization of trigeminal ganglia by attenuated strains of pseudorabies virus and resistance to wild-type virus latency.

Authors:  L M Schang; G F Kutish; F A Osorio
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress.

Authors:  M E Whealy; J P Card; R P Meade; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.